Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Gynecology

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 41 articles: HTML format Text format

Single Articles

May 2012
1. NIELSEN JS , Sahota RA, Milne K, Kost SE, et al
   CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
   Clin Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
2. SHAN W , Akinfenwa PY, Brewer Savannah K, Kolomeyevskaya N, et al
   A small molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.
   Clin Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. KIM KH , Dmitriev I, O'Malley JP, Wang M, et al
   A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer.
   Clin Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. GILLET JP , Calcagno AM, Varma S, Davidson B, et al
   Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients With Primary Ovarian Serous Carcinoma.
   Clin Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
5. CHAMBERS SK , Chow HH, Janicek MF, Cragun JM, et al
   Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.
   Clin Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
6. YOSHIHARA K , Tsunoda T, Shigemizu D, Fujiwara H, et al
   High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by down-regulation of antigen presentation pathway.
   Clin Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SCHWARZ JK , Payton JE, Rashmi R, Xiang T, et al
   Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer.
   Clin Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
8. KLOPP AH , Zhang Y, Solley T, Amaya-Manzanares F, et al
   Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.
   Clin Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LOCASALE JW , Zeskind B
   IL-6 and Ovarian Cancer--Letter.
   Clin Cancer Res. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
10. BALKWILL FR , Coward J, Kulbe H, Milagre C, et al
    IL-6 and Ovarian Cancer--Response.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. KORETS SB , Czok S, Blank SV, Curtin JP, et al
    Targeting the mTOR/4E-BP Pathway in Endometrial Cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. STEG AD , Bevis KS, Katre AA, Ziebarth A, et al
    Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
13. MOHEBTASH M , Tsang KY, Madan RA, Huen NY, et al
    A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
14. WITTINGER M , Vanhara P, El-Gazzar A, Brenner B, et al
    hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. RISCH HA , Berchuck A, Paul DP
    KRAS rs61764370 in Epithelial Ovarian Cancer-Response.
    Clin Cancer Res. 2011;17:6601.
    PubMed     Text format     Related articles   
    
    
    
    
16. WEIDHAAS JB , Slack FJ
    KRAS rs61764370 in Epithelial Ovarian Cancer-Letter.
    Clin Cancer Res. 2011;17:6600.
    PubMed     Text format     Related articles   
    
    
    
    
17. BAGO-HORVATH Z , Rudas M, Dubsky P, Jakesz R, et al
    Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. HUNTER SM , Anglesio MS, Sharma R, Gilks B, et al
    Copy number aberrations in benign serous ovarian tumors: a case for reclassification?
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
19. COLDITZ G , Crowley J
    DNA cytometry testing for cervical cancer screening: approaches and reporting standards for new technologies.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. JIANG L , Siu MK, Wong OG, Tam KF, et al
    iASPP and Chemoresistance in Ovarian Cancers - Effects on Paclitaxel-Mediated Mitotic Catastrophe.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MIYAMOTO S , Iwamoto R, Furuya A, Takahashi K, et al
    A Novel Anti-Human HB-EGF Monoclonal Antibody with Multiple Anti-Tumor Mechanisms Against Ovarian Cancer Cells.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. WU R , Hu T, Rehemtulla A, Fearon ER, et al
    Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. MORONEY JW , Schliumbrecht MP, Helgason T, Coleman R, et al
    A Phase I Trial of Liposomal Doxorubicin, Bevacizumab and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
24. MARCHION DC , Cottrill HM, Xiong Y, Chen N, et al
    BAD phosphorylation determines ovarian cancer chemo-sensitivity and patient survival.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
25. COWARD J , Kulbe H, Chakravarty P, Leader DA, et al
    Interleukin-6 as a therapeutic target in human ovarian cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. STEG AD , Katre AA, Goodman BW, Han HD, et al
    Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. HALLE C , Lando M, Svendsrud DH, Clancy T, et al
    Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor (EGFR) Predicts Outcome after Chemoradiotherapy of Lymph Node Negative Cervical Cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. MATSUO K , Nishimura M, Bottsford-Miller J, Huang J, et al
    Targeting Src in Mucinous Ovarian Carcinoma.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
29. HUANG RS , Johnatty SE, Gamazon ER, Im HK, et al
    Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
30. MABUCHI S , Hisamatsu T, Kawase C, Hayashi M, et al
    The activity of trabectedin as a single agent or in combination with everolimus for clear cell carcinoma of the ovary.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. STAFF AC , Trovik J, Eriksson AG, Wik E, et al
    Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. ITAMOCHI H , Oishi T, Shimada M, Sato S, et al
    Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through up-regulation of c-Jun.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. FARATIAN D , Zweemer A, Nagumo Y, Sims AH, et al
    Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ZILLHARDT M , Park SM, Romero IL, Sawada K, et al
    Foretinib (GSK1363089), an orally available multi-kinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
35. MORENO-SMITH M , Lu C, Shahzad MM, Armaiz-Pena GN, et al
    Dopamine blocks stress mediated ovarian carcinoma growth.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
36. VIVAS-MEJIA PE , Rodriguez-Aguayo C, Han HD, Shahzad MM, et al
    Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
37. HESSELINK AT , Heideman DA, Steenbergen RD, Coupe VM, et al
    Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Clin Cancer Res. 2011;17:2459-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. DAI W , Teodoridis J, Zeller C, Graham JS, et al
    Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
39. CHAKRAVARTY D , Saha Roy S, Challa R, Dandamudi R, et al
    Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
    Clin Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. TAN DS , Iravani M, McCluggage WG, Lambros MB, et al
    Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas.
    Clin Cancer Res. 2011;17:1521-1534.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MIZUMOTO Y , Kyo S, Kiyono T, Takakura M, et al
    Activation of NF-{kappa}B Is a Novel Target of KRAS-Induced Endometrial Carcinogenesis.
    Clin Cancer Res. 2011;17:1341-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: